102 related articles for article (PubMed ID: 22367657)
1. The anticonvulsant levetiracetam potentiates alcohol consumption in non-treatment seeking alcohol abusers.
Mitchell JM; Grossman LE; Coker AR; Messing RO
J Clin Psychopharmacol; 2012 Apr; 32(2):269-72. PubMed ID: 22367657
[TBL] [Abstract][Full Text] [Related]
2. Single-dose bioavailability of levetiracetam intravenous infusion relative to oral tablets and multiple-dose pharmacokinetics and tolerability of levetiracetam intravenous infusion compared with placebo in healthy subjects.
Ramael S; De Smedt F; Toublanc N; Otoul C; Boulanger P; Riethuisen JM; Stockis A
Clin Ther; 2006 May; 28(5):734-44. PubMed ID: 16861095
[TBL] [Abstract][Full Text] [Related]
3. A double-blind, placebo-controlled trial assessing the efficacy of levetiracetam extended-release in very heavy drinking alcohol-dependent patients.
Fertig JB; Ryan ML; Falk DE; Litten RZ; Mattson ME; Ransom J; Rickman WJ; Scott C; Ciraulo D; Green AI; Tiouririne NA; Johnson B; Pettinati H; Strain EC; Devine E; Brunette MF; Kampman K; A Tompkins D; Stout R;
Alcohol Clin Exp Res; 2012 Aug; 36(8):1421-30. PubMed ID: 22324516
[TBL] [Abstract][Full Text] [Related]
4. Effect of levetiracetam on cardiac repolarization in healthy subjects: a single-dose, randomized, placebo- and active-controlled, four-way crossover study.
Hulhoven R; Rosillon D; Bridson WE; Meeus MA; Salas E; Stockis A
Clin Ther; 2008 Feb; 30(2):260-70. PubMed ID: 18343264
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of valproate maintenance in patients with bipolar disorder and alcoholism: a double-blind placebo-controlled study.
Salloum IM; Cornelius JR; Daley DC; Kirisci L; Himmelhoch JM; Thase ME
Arch Gen Psychiatry; 2005 Jan; 62(1):37-45. PubMed ID: 15630071
[TBL] [Abstract][Full Text] [Related]
6. Voluntary alcohol consumption and plasma beta-endorphin levels in alcohol preferring rats chronically treated with levetiracetam: a preliminary study.
Zalewska-Kaszubska J; Bajer B; Czarnecka E; Dyr W; Gorska D
Physiol Behav; 2011 Mar; 102(5):538-41. PubMed ID: 21187108
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of levetiracetam for outpatient alcohol detoxification.
Müller CA; Schäfer M; Schneider S; Heimann HM; Hinzpeter A; Volkmar K; Förg A; Heinz A; Hein J
Pharmacopsychiatry; 2010 Jul; 43(5):184-9. PubMed ID: 20503149
[TBL] [Abstract][Full Text] [Related]
8. Levetiracetam in the treatment of alcohol dependence: toward the end of the story?
Le Strat Y
Alcohol Clin Exp Res; 2012 Aug; 36(8):1309-10. PubMed ID: 22823576
[TBL] [Abstract][Full Text] [Related]
9. The effect of levetiracetam on tremor severity and functionality in patients with multiple sclerosis.
Feys P; D'hooghe MB; Nagels G; Helsen WF
Mult Scler; 2009 Mar; 15(3):371-8. PubMed ID: 19168602
[TBL] [Abstract][Full Text] [Related]
10. Levetiracetam and bleeding disorders.
Boon P; Hulhoven R; Offner F
Acta Neurol Belg; 2007 Dec; 107(4):97-102. PubMed ID: 18416281
[TBL] [Abstract][Full Text] [Related]
11. Does participation in an alcohol administration study increase risk for excessive drinking?
Pratt WM; Davidson D
Alcohol; 2005 Nov; 37(3):135-41. PubMed ID: 16713501
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of levetiracetam for the prevention of alcohol relapse in recently detoxified alcohol-dependent patients: a randomized trial.
Richter C; Effenberger S; Bschor T; Bonnet U; Haasen C; Preuss UW; Heinz A; Förg A; Volkmar K; Glauner T; Schaefer M
J Clin Psychopharmacol; 2012 Aug; 32(4):558-62. PubMed ID: 22722516
[TBL] [Abstract][Full Text] [Related]
13. WHO/ISBRA Study on State and Trait Markers of Alcohol Use and Dependence: analysis of demographic, behavioral, physiologic, and drinking variables that contribute to dependence and seeking treatment. International Society on Biomedical Research on Alcoholism.
Glanz J; Grant B; Monteiro M; Tabakoff B;
Alcohol Clin Exp Res; 2002 Jul; 26(7):1047-61. PubMed ID: 12170115
[TBL] [Abstract][Full Text] [Related]
14. Pilot efficacy and tolerability: a randomized, placebo-controlled trial of levetiracetam for essential tremor.
Handforth A; Martin FC
Mov Disord; 2004 Oct; 19(10):1215-21. PubMed ID: 15390011
[TBL] [Abstract][Full Text] [Related]
15. Double-blind placebo-controlled trial of adjunctive levetiracetam in pediatric partial seizures.
Glauser TA; Ayala R; Elterman RD; Mitchell WG; Van Orman CB; Gauer LJ; Lu Z;
Neurology; 2006 Jun; 66(11):1654-60. PubMed ID: 16641323
[TBL] [Abstract][Full Text] [Related]
16. Levetiracetam in primary orthostatic tremor: a double-blind placebo-controlled crossover study.
Hellriegel H; Raethjen J; Deuschl G; Volkmann J
Mov Disord; 2011 Nov; 26(13):2431-4. PubMed ID: 21953629
[TBL] [Abstract][Full Text] [Related]
17. A pilot double-blind treatment trial of memantine for alcohol dependence.
Evans SM; Levin FR; Brooks DJ; Garawi F
Alcohol Clin Exp Res; 2007 May; 31(5):775-82. PubMed ID: 17378918
[TBL] [Abstract][Full Text] [Related]
18. Levetiracetam versus placebo in childhood and adolescent autism: a double-blind placebo-controlled study.
Wasserman S; Iyengar R; Chaplin WF; Watner D; Waldoks SE; Anagnostou E; Soorya L; Hollander E
Int Clin Psychopharmacol; 2006 Nov; 21(6):363-7. PubMed ID: 17012983
[TBL] [Abstract][Full Text] [Related]
19. Multicenter double-blind, randomized, placebo-controlled trial of levetiracetam as add-on therapy in Chinese patients with refractory partial-onset seizures.
Wu XY; Hong Z; Wu X; Wu LW; Wang XF; Zhou D; Zhao ZX; Lv CZ
Epilepsia; 2009 Mar; 50(3):398-405. PubMed ID: 18657175
[TBL] [Abstract][Full Text] [Related]
20. Once-daily extended-release levetiracetam as adjunctive treatment of partial-onset seizures in patients with epilepsy: a double-blind, randomized, placebo-controlled trial.
Peltola J; Coetzee C; Jiménez F; Litovchenko T; Ramaratnam S; Zaslavaskiy L; Lu ZS; Sykes DM;
Epilepsia; 2009 Mar; 50(3):406-14. PubMed ID: 19317886
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
